Brief: Petros Pharmaceuticals Says Confirmed A Press Release Issued On July 28, 2022 Regarding Purported Acquisition Of Co Was Fraudulent And Not Issued By Co
28/07/2022 15:36
July 28 (Reuters) - Petros Pharmaceuticals Inc PTPI.O :
* PETROS PHARMACEUTICALS - CONFIRMED A PRESS RELEASE ISSUED
ON
JULY 28, 2022 REGARDING PURPORTED ACQUISITION OF CO WAS
FRAUDULENT AND NOT ISSUED BY CO
* PETROS PHARMACEUTICALS INC - NOT A PARTY TO ANY SUCH
ACQUISITION
AND HAS REPORTED FRAUDULENT ACTIVITY TO NASDAQ
Source text for Eikon: GNXYvVWr
Further company coverage: PTPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Petros Pharmaceuticals
See all newsBrief: Petros Pharmaceuticals Assigns All Assets To Pt Liquidation, For Benefit Of Creditors
Brief: Petros Pharmaceuticals’ STENDRA Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
Brief: Petros Pharmaceuticals Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: Petros Pharmaceuticals Expands Online Distribution For Prescription STENDRA(R) Through New Agreement With Lemonaid Health
Brief: Petros Pharma Announces Partnership with Idea Evolver for Rx-to-OTC Switches & Digital Launch Solutions